Candel Therapeutics (CADL) shares were down about 15% in recent Wednesday trading after BofA Securities lowered its rating on the stock to neutral from buy.
Trading volume stood at 2 million shares compared with a daily average of about 833,293 shares.
Price: 5.01, Change: -0.86, Percent Change: -14.59